The Genentech / ASCI Early-Career Impact Awards program seeks to enhance the understanding of disease mechanisms, accelerate translational discoveries, and drive the development of cutting-edge diagnostics and therapies. These Awards support the work of physician-scientists who are early in their first full-time faculty appointment and who are conducting impactful research in one of Genentech’s therapeutic areas of interest.
Up to 2 awards will be awarded this year in the amount of $100,000 a year for 3 years.
The nomination process is currently open, click here for more information.
Eligible nominees:
- are from an U.S.-accredited university / research institution that is able to commit to matching the award amount of $100,000/year for 3 years,
- hold an MD, MD/PhD, or equivalent degree,
- be in the first three years of their first academic appointment at the Instructor or Assistant Professor or equivalent level (tenure- and non-tenure-track) as of the Award start date,
- can dedicate more than 75% of their time to research activities,
- conduct research in one of Genentech’s therapeutic areas of interest:
- Cardiovascular, renal, and metabolic disease
- Immunology
- Infectious disease
- Neuroscience
- Oncology
- Ophthalmology
- and are in good standing at their institution.
Nominees are nominated by an ASCI member, who does not have to be from the nominee’s institution. The ASCI Directory is linked here (searchable by name, institution, specialty, etc.).
In addition to financial support, award benefits include:
- Complimentary registration to the AAP/ASCI/APSA Joint Meeting
- Access to ASCI Early-Career programming
For questions, contact staff@the-asci.org.